Figure 2From: The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition Power analysis for the minimum detectable difference between the 3 groups in the change in outcome from baseline to 12 months of the AVEC trial. (assuming alpha = 0.05 and power = 80%)Back to article page